DK0633028T3 - Vaccine imod Lyme-sygdommen - Google Patents

Vaccine imod Lyme-sygdommen

Info

Publication number
DK0633028T3
DK0633028T3 DK94112145T DK94112145T DK0633028T3 DK 0633028 T3 DK0633028 T3 DK 0633028T3 DK 94112145 T DK94112145 T DK 94112145T DK 94112145 T DK94112145 T DK 94112145T DK 0633028 T3 DK0633028 T3 DK 0633028T3
Authority
DK
Denmark
Prior art keywords
lyme disease
vaccine against
against lyme
antigen
auxiliaries
Prior art date
Application number
DK94112145T
Other languages
English (en)
Inventor
Markus M Dr Simon
Ulrich E Schaible
Klaus Prof Dr Eichmann
Michael Dr Kramer
Reinhard Dr Wallich
Original Assignee
Deutsches Krebsforsch
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25885304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0633028(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Deutsches Krebsforsch, Max Planck Gesellschaft filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of DK0633028T3 publication Critical patent/DK0633028T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1207—Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94112145T 1989-09-19 1990-09-18 Vaccine imod Lyme-sygdommen DK0633028T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3931236 1989-09-19
DE4015911A DE4015911A1 (de) 1989-09-19 1990-05-17 Impfstoff gegen die lyme-krankheit

Publications (1)

Publication Number Publication Date
DK0633028T3 true DK0633028T3 (da) 2000-04-10

Family

ID=25885304

Family Applications (4)

Application Number Title Priority Date Filing Date
DK94112145T DK0633028T3 (da) 1989-09-19 1990-09-18 Vaccine imod Lyme-sygdommen
DK94112144T DK0633313T3 (da) 1989-09-19 1990-09-18 Vaccine mod Lyme-sygdom
DK94112143T DK0643974T3 (da) 1989-09-19 1990-09-18 Vaccine mod Lyme-sygdom
DK90117943.2T DK0418827T3 (da) 1989-09-19 1990-09-18 Vaccine mod Lyme-sygdom

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK94112144T DK0633313T3 (da) 1989-09-19 1990-09-18 Vaccine mod Lyme-sygdom
DK94112143T DK0643974T3 (da) 1989-09-19 1990-09-18 Vaccine mod Lyme-sygdom
DK90117943.2T DK0418827T3 (da) 1989-09-19 1990-09-18 Vaccine mod Lyme-sygdom

Country Status (23)

Country Link
US (6) US5178859A (da)
EP (5) EP0418827B1 (da)
JP (3) JP3205932B2 (da)
KR (2) KR100205462B1 (da)
AT (4) ATE186646T1 (da)
AU (1) AU651560B2 (da)
CA (1) CA2025597C (da)
CZ (2) CZ284616B6 (da)
DE (5) DE4015911A1 (da)
DK (4) DK0633028T3 (da)
ES (4) ES2141182T3 (da)
FI (1) FI102248B (da)
GR (3) GR3018995T3 (da)
HR (1) HRP940545B1 (da)
HU (2) HU212716B (da)
IE (1) IE903377A1 (da)
NO (2) NO311767B1 (da)
NZ (1) NZ235260A (da)
PL (2) PL169804B1 (da)
PT (1) PT95349B (da)
SI (1) SI9011773B (da)
SK (3) SK283088B6 (da)
YU (2) YU48250B (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US7094391B1 (en) * 1988-10-24 2006-08-22 The University Of Texas System Compositions and methods for administering Borrelia burgdorferi antigens
US5777095A (en) * 1988-10-24 1998-07-07 Symbicom Aktiebolag Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
US6143872A (en) * 1988-10-24 2000-11-07 Symbicom Aktiebolag Borrelia burdorferi Osp A and B proteins and immunogenic peptides
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
US5582829A (en) * 1990-04-05 1996-12-10 Rx Technologies, Inc. Sonicated borrelia burgdorferi vaccine
CA2084413A1 (en) 1990-06-15 1991-12-16 Richard A. Flavell Compositions and methods for the prevention and diagnosis of lyme disease
EP1016416A3 (en) * 1990-07-06 2002-10-23 Wyeth Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy
CA2057536C (en) * 1990-12-21 1999-10-26 John J. Dunn Cloning and expression of borrelia lipoproteins
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
US6872550B1 (en) 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
US6113914A (en) * 1991-08-15 2000-09-05 Smithkline Beecham Biologicals (S.A.) Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
US6676942B1 (en) * 1991-08-15 2004-01-13 Smithkline Beecham Biologicals (S.A.) Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
PT100980B (pt) * 1991-10-18 1999-07-30 Connaught Lab Proteinas recombinantes de borrelia, seu processo de producao, vacina contra infeccao por borrelia e agente de imunodiagnostico para a sua deteccao
ES2194010T3 (es) * 1991-10-22 2003-11-16 Symbicom Ab Mejoras en el diagnostico y profilaxis de la borrelia burgdorferi.
US6303129B1 (en) * 1992-07-28 2001-10-16 Rx Technologies Production of borrelia burgdorferi vaccine, product produced thereby and method of use
US6716591B1 (en) 1993-07-30 2004-04-06 Yale University B. burgdorferi polypeptides
US5656451A (en) * 1993-07-30 1997-08-12 Yale University OspE, OspF, and S1 polypeptides in borrelia burgdorferi
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
US5558993A (en) * 1994-06-17 1996-09-24 The Regents Of The University Of California Cloned Borrelia burgdorferi virulence protein
GB9511909D0 (en) * 1995-06-12 1995-08-09 Microbiological Res Authority Vaccine
EP1589109B1 (en) 1996-02-21 2017-04-12 Board of Regents, The University of Texas System VMP-like sequences of pathogenic borrelia
DE19632862B4 (de) 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
US6458555B1 (en) * 1996-08-21 2002-10-01 Gerd Bach Cytologic method of examining mucous membranes
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
DE19740735A1 (de) * 1997-09-16 1999-03-18 Max Planck Gesellschaft Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
US6306623B1 (en) 1998-02-24 2001-10-23 The University Of California Leptospiral major outer membrane protein LipL32
EP1100922B1 (en) 1998-07-31 2008-02-20 Gundersen Lutheran Medical Foundation, Inc. Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
WO2000056298A2 (en) * 1999-03-19 2000-09-28 Luitpold Pharmaceuticals, Inc. Treatment of lyme disease with polysulfated glycosaminoglycan formulations
AU4800500A (en) * 1999-06-21 2001-01-09 Milkhaus Laboratory, Inc. Method for treatment of lyme disease
ATE381575T1 (de) 2000-08-18 2008-01-15 Univ New York State Res Found Veränderte borrelia burgdorferi ospa
WO2004058181A2 (en) 2002-12-20 2004-07-15 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia species and strains
UA99719C2 (ru) 2006-11-03 2012-09-25 Шеринг-Плау Лтд. Вакцина для собак против болезни лайма
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP3620465B1 (en) 2007-07-03 2025-02-19 Dako Denmark A/S Improved methods for generation, labeling and use of mhc multimers
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
EP2501719B1 (en) * 2009-11-17 2015-11-04 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
PL223175B1 (pl) 2012-10-22 2016-10-31 Inst Chemii Bioorganicznej Polskiej Akademii Nauk Szczepionka przeciw boreliozie, konstrukt genetyczny, rekombinowane białko, sposób otrzymywania konstruktu genetycznego, sposób otrzymywania szczepionki, sposób otrzymywania rekombinowanych białek, zastosowanie rekombinowanych białek do wytwarzania szczepionki przeciwko boreliozie
US9610336B1 (en) * 2014-07-16 2017-04-04 Amiram Katz Immunotherapy for lyme disease
WO2020127222A2 (en) 2018-12-17 2020-06-25 Immudex Aps Panel comprising borrelia mhc multimers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4772464A (en) 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4888276A (en) * 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US5034515A (en) * 1987-09-22 1991-07-23 Wisconsin Alumni Research Foundation Staphylococcal fibronectin receptor, monoclonal antibodies thereto and methods of use
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
DK0506868T4 (da) * 1989-12-22 2004-04-26 Mikrogen Molekularbiol Entw Immunologisk aktive proteiner fra Borrelia burgdorferi, tilhørende testkits og vaccine
CA2084413A1 (en) * 1990-06-15 1991-12-16 Richard A. Flavell Compositions and methods for the prevention and diagnosis of lyme disease
EP1016416A3 (en) * 1990-07-06 2002-10-23 Wyeth Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy
CA2057536C (en) * 1990-12-21 1999-10-26 John J. Dunn Cloning and expression of borrelia lipoproteins
US6113914A (en) * 1991-08-15 2000-09-05 Smithkline Beecham Biologicals (S.A.) Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
EP0642574B1 (en) * 1991-08-27 1998-12-09 Novo Nordisk A/S Detergent compositions
PT100980B (pt) * 1991-10-18 1999-07-30 Connaught Lab Proteinas recombinantes de borrelia, seu processo de producao, vacina contra infeccao por borrelia e agente de imunodiagnostico para a sua deteccao
JPH07502646A (ja) * 1991-10-21 1995-03-23 メディミューン，インコーポレーテッド リポタンパク質の分泌シグナルをコード化するｄｎａを含む細菌発現ベクター

Also Published As

Publication number Publication date
DE4015911A1 (de) 1991-03-28
JP2001204467A (ja) 2001-07-31
ATE191499T1 (de) 2000-04-15
DE59010888D1 (de) 1999-12-23
ATE131732T1 (de) 1996-01-15
ES2141182T3 (es) 2000-03-16
GR3018995T3 (en) 1996-05-31
EP0633313A1 (de) 1995-01-11
JP2001069969A (ja) 2001-03-21
EP0633313B1 (de) 2000-04-05
HRP940545B1 (en) 2000-06-30
SK456090A3 (en) 1999-11-08
SK283089B6 (sk) 2003-02-04
ES2082812T3 (es) 1996-04-01
JP3328644B2 (ja) 2002-09-30
IE990173A1 (en) 2000-11-01
HU212716B (en) 1996-10-28
FI904597A0 (fi) 1990-09-18
HU905816D0 (en) 1991-03-28
HK1013620A1 (en) 1999-09-03
CA2025597A1 (en) 1991-03-20
HRP940545A2 (en) 1997-04-30
SK151198A3 (en) 1999-04-13
US5686267A (en) 1997-11-11
CZ284538B6 (cs) 1998-12-16
EP0861664A2 (de) 1998-09-02
DK0643974T3 (da) 1999-09-06
SK151098A3 (en) 1999-04-13
YU48250B (sh) 1997-09-30
PL170229B1 (pl) 1996-11-29
HU211228A9 (en) 1995-11-28
ATE186646T1 (de) 1999-12-15
EP0633028B1 (de) 1999-11-17
EP0643974B1 (de) 1999-01-13
US6613331B1 (en) 2003-09-02
DE59010903D1 (de) 2000-05-11
PT95349B (pt) 1997-06-30
YU177390A (sh) 1993-05-28
US5856447A (en) 1999-01-05
GR3032010T3 (en) 2000-03-31
DE59009978D1 (de) 1996-02-01
EP0633028A1 (de) 1995-01-11
NO904062L (no) 1991-03-20
US5780030A (en) 1998-07-14
CZ284616B6 (cs) 1999-01-13
CZ456090A3 (cs) 1998-08-12
SK280285B6 (sk) 1999-11-08
EP0861664A3 (de) 1999-02-24
YU9097A (sh) 1999-06-15
JPH03209400A (ja) 1991-09-12
HK1002405A1 (en) 1998-08-21
DK0418827T3 (da) 1996-05-06
AU6244490A (en) 1991-03-28
ES2145077T3 (es) 2000-07-01
EP0418827A1 (de) 1991-03-27
HUT59613A (en) 1992-06-29
JP3205932B2 (ja) 2001-09-04
IE903377A1 (en) 1991-04-10
YU49370B (sh) 2005-09-19
SI9011773A (sl) 1998-04-30
SK283088B6 (sk) 2003-02-04
NO904062D0 (no) 1990-09-18
FI102248B1 (fi) 1998-11-13
NO311767B1 (no) 2002-01-21
NO20014624D0 (no) 2001-09-24
US5178859A (en) 1993-01-12
FI102248B (fi) 1998-11-13
NO315905B1 (no) 2003-11-10
NZ235260A (en) 1993-04-28
DK0633313T3 (da) 2000-07-24
AU651560B2 (en) 1994-07-28
EP0418827B1 (de) 1995-12-20
GR3033675T3 (en) 2000-10-31
CA2025597C (en) 2004-02-03
CZ97095A3 (en) 1995-09-13
KR100202128B1 (en) 1999-06-15
PT95349A (pt) 1991-05-22
JP3418171B2 (ja) 2003-06-16
DE59010863D1 (de) 1999-02-25
US5434077A (en) 1995-07-18
SI9011773B (en) 2001-12-31
ES2129551T3 (es) 1999-06-16
ATE175576T1 (de) 1999-01-15
NO20014624L (no) 1991-03-20
KR100205462B1 (ko) 1999-07-01
KR910005889A (ko) 1991-04-27
PL169804B1 (pl) 1996-09-30
EP0643974A1 (de) 1995-03-22

Similar Documents

Publication Publication Date Title
DK0633028T3 (da) Vaccine imod Lyme-sygdommen
PT100781A (pt) Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas
PT721506E (pt) Proteinas exportadas bacterianas e vacinas acelulares baseadas nestas
DK0626452T3 (da) Vaccine mod infektion af Streptococcus suis
ATE121754T1 (de) Vakzine gegen bordetella.
FI910398A0 (fi) Rekombinant coccidiosisvaccin -5-7-eimeria-ytantigen.
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
IT1223416B (it) Procedimento per la realizzazione di calzature del tipo ciabatta, nonche' ciabatta cosi' realizzata
ATE98962T1 (de) Menschliche rhinoviruspeptide.